Viewing Study NCT02197169


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2026-01-13 @ 12:40 AM
Study NCT ID: NCT02197169
Status: COMPLETED
Last Update Posted: 2018-07-16
First Post: 2014-07-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
Sponsor: DNAtrix, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module